CLOSE

Technology Transfer Factor (TTF)

Highlight

TTFactor: "A company facing companies” created to support researchers and clinicians in evaluating the commercial potential of their research and promoting relationships with industry.

More information about technology transfer at IEO:  www.ttfactor.com

Mission&Vision

TTFactor is technology transfer company of the European Institute of Oncology (IEO) and the FIRC Institute for Molecular Oncology (IFOM), its mission is in supporting researchers and clinician in evaluating the commercial potential of their research and promoting relationships with industry to foster further application and development of their research results and inventions. Typical TTF activities include patent filing, licensing, sponsored research and spin off creation.

Explore the patent opportunities available for licensing at: www.ttfactor.com/for-companies

  • Board of Directors & Business Development Advisory Board

    TTFactor counts of a Board of Directors composed by the representatives of IFOM and IEO, together with highly reputed international industry and technology transfer professionals, as well as a Business Development Advisory Board chaired by the Director of Applied Cancer Science at MD Anderson Cancer Center.
    This team of experts has been created to serve scientists and ensure both Institutes that their intellectual properties are valued in accordance with fair principles, that means on the basis of their impact on patient’s care and their ability to become commercial products attractive for the industry.

    Board of Directors

    Chairman of the Board

    Pier Giuseppe Pelicci


    New York University

    Claudio Basilico

     

    ST Microelectronics

    Andrea Cuomo

     

    IFOM

    Marco Foiani

     

    Harvard University

    Isaac Kohlberg

     

    Cancer Research UK

    Tomas Lindhal

     

    FIRC

    Elisabetta Petrucci

    IFOM

    Leonardo Biondi

     

    IEO

    Domenico Triarico

     

    IEO

    Mario Cesana

     

     

    Business Development Advisory Board

    Director, MD Anderson Institute for Applied Cancer Science

    Giulio Draetta

     

     

    Managing Partner at MPM Capital, Venture Capitalist

    Kazumi Shiosaki


     


    Senior Associate Provost and Chief Technology Development Officer at Harvard University

    Isaac Kohlberg

     

    Senior Vice President, Research at Scholar Rock LLC

    Katherine Turner

    CEO & President at Scholar Rock LLC

    Nagesh Mahantappa


     

     

A SMALL GESTURE IS A GREAT HELP FOR US

PARTNERSHIP

Università degli Studi di Milano Ecancer Medical Science IFOM-IEO Campus

CREDITS

Ministero della Salute Joint Commission International Breastcertification bollinirosa

© 2013 Istituto Europeo di Oncologia - via Ripamonti 435 Milano - P.I. 08691440153

IRCCS - ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO

facebook IEO googleplus IEO twitter IEO pinterest IEO vimeo IEO